Showing results (11-20 of 118) with videos related to
Sort By:
Pageof 12
Oncogene|September 1, 2022
GPNMB: a potent inducer of immunosuppression in cancerAnna-Maria Lazaratos, Matthew G Annis, Peter M SiegelJournal of Cellular Biochemistry|July 9, 2016
The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic ResponsivenessJacqueline R Ha, Peter M Siegel, Josie Ursini-SiegelJournal of Cell Communication and Signaling|October 14, 2017
Emerging roles for LPP in metastatic cancer progressionElaine Ngan, Alex Kiepas, Claire M Brown, et al.Cell|August 2, 2002
E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repressionChang-Rung Chen, Yibin Kang, Peter M Siegel, et al.Oncotargets and Therapy|July 23, 2013
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancerGordana Maric, April An Rose, Matthew G Annis, et al.Pharmacology & Therapeutics|May 27, 2017
Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancerApril A N Rose, Marco Biondini, Rafael Curiel, et al.Scientific Reports|November 8, 2019
CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitroShufeng Zhou, Sabrina Daniela da Silva, Peter M Siegel, et al.Journal of Cell Science|January 29, 2020
Optimizing live-cell fluorescence imaging conditions to minimize phototoxicityAlex Kiepas, Elena Voorand, Firas Mubaid, et al.Molecular & Cellular Proteomics : MCP|February 15, 2015
Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarrayHuiyan Li, Sébastien Bergeron, Matthew G Annis, et al.Cancer Research|September 3, 2016
Metabolic Plasticity as a Determinant of Tumor Growth and MetastasisCamille Lehuédé, Fanny Dupuy, Rebecca Rabinovitch, et al.Pageof 12